Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Internal biliary stenting during orthotopic liver transplantation: anastomotic complications, post-transplant biliary interventions, and survival.

Mathur AK, Nadig SN, Kingman S, Lee D, Kinkade K, Sonnenday CJ, Welling TH.

Clin Transplant. 2015 Apr;29(4):327-35. doi: 10.1111/ctr.12518. Epub 2015 Feb 23.

PMID:
25604635
2.

Induction therapy: clinical and quality of life outcomes in aged renal transplant recipients.

Palanisamy AP, Al Manasra AR, Pilch NA, Dowden JE, Nadig SN, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ.

Clin Transplant. 2015 Mar;29(3):222-6. doi: 10.1111/ctr.12507. Epub 2015 Jan 27.

PMID:
25557762
3.

Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis.

Palanisamy AP, Schiltz CE 3rd, Pilch NA, Hunt KJ, Nadig SN, Dowden JE, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ.

Blood Press. 2015 Feb;24(1):14-22. doi: 10.3109/08037051.2014.934527. Epub 2014 Jul 22.

PMID:
25048253
4.

Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group.

Mellinger JL, Rossaro L, Naugler WE, Nadig SN, Appelman H, Lee WM, Fontana RJ.

Dig Dis Sci. 2014 Jul;59(7):1630-7. doi: 10.1007/s10620-014-3029-2. Epub 2014 Jan 25. Review.

5.

Ex vivo expanded human regulatory T cells can prolong survival of a human islet allograft in a humanized mouse model.

Wu DC, Hester J, Nadig SN, Zhang W, Trzonkowski P, Gray D, Hughes S, Johnson P, Wood KJ.

Transplantation. 2013 Oct 27;96(8):707-16. doi: 10.1097/TP.0b013e31829fa271.

6.

Preoperative medication management: filling in the gaps.

Nadig SN, Wright Nunes JA.

South Med J. 2013 Aug;106(8):447-8. doi: 10.1097/SMJ.0b013e3182a05875. No abstract available.

PMID:
23912136
7.

A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years.

Pelletier SJ, Nadig SN, Lee DD, Ammori JB, Englesbe MJ, Sung RS, Magee JC, Fontana RJ, Punch JD.

HPB (Oxford). 2013 Apr;15(4):286-93. doi: 10.1111/j.1477-2574.2012.00576.x. Epub 2012 Sep 28.

8.

Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.

Schiopu A, Nadig SN, Cotoi OS, Hester J, van Rooijen N, Wood KJ.

Atherosclerosis. 2012 Aug;223(2):291-8. doi: 10.1016/j.atherosclerosis.2012.05.010. Epub 2012 May 19.

9.

Clinical implications of mucinous nonneoplastic cysts of the pancreas.

Nadig SN, Pedrosa I, Goldsmith JD, Callery MP, Vollmer CM.

Pancreas. 2012 Apr;41(3):441-6. doi: 10.1097/MPA.0b013e318229b9b8.

PMID:
22015974
10.

Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.

Feng G, Nadig SN, Bäckdahl L, Beck S, Francis RS, Schiopu A, Whatcott A, Wood KJ, Bushell A.

Sci Transl Med. 2011 May 18;3(83):83ra40. doi: 10.1126/scitranslmed.3002099.

11.

Living donor kidney transplantation at the University of Michigan.

Lee DD, Gooden CW, Nadig SN, Sonnenday CJ, Abbott C, Magee JC, Englesbe MJ, Punch JD, Samaniego M, Merion RM, Sung RS.

Clin Transpl. 2011:77-89.

PMID:
22755404
12.

Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.

Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K.

Transplantation. 2010 Dec 27;90(12):1321-7. doi: 10.1097/TP.0b013e3181ff8772.

13.

In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.

Nadig SN, Wieckiewicz J, Wu DC, Warnecke G, Zhang W, Luo S, Schiopu A, Taggart DP, Wood KJ.

Nat Med. 2010 Jul;16(7):809-13. doi: 10.1038/nm.2154. Epub 2010 May 16.

14.

CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis.

Warnecke G, Feng G, Goto R, Nadig SN, Francis R, Wood KJ, Bushell A.

Am J Pathol. 2010 Jul;177(1):464-72. doi: 10.2353/ajpath.2010.090292. Epub 2010 May 14.

15.

Transplantation tolerance: lessons from experimental rodent models.

Kingsley CI, Nadig SN, Wood KJ.

Transpl Int. 2007 Oct;20(10):828-41. Epub 2007 Aug 17. Review.

16.

Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo.

Warnecke G, Bushell A, Nadig SN, Wood KJ.

Transplantation. 2007 Jun 15;83(11):1459-65.

PMID:
17565319
17.

Marginal donors in liver transplantation: expanding the donor pool.

Nadig SN, Bratton CF, Karp SJ.

J Surg Educ. 2007 Jan-Feb;64(1):46-50. No abstract available.

PMID:
17320806
18.

Hepatocellular ultrastructure after ischemia/reperfusion injury in human orthotopic liver transplantation.

Nadig SN, Periyasamy B, Shafizadeh SF, Polito C, Fiorini RN, Rodwell D, Evans Z, Cheng G, Dunkelberger D, Schmidt M, Self SE, Chavin KD.

J Gastrointest Surg. 2004 Sep-Oct;8(6):695-700.

PMID:
15358330
19.

"Drowned lung" following lobectomy and radiation therapy: a case report.

Nadig SN, Block MI.

J S C Med Assoc. 2003 Feb;99(2):26-9.

PMID:
12664823
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk